
Telomir Pharmaceuticals Inc. (NASDAQ:TELO) shares surged 35.14% in after-hours trading to $2.00 on Wednesday, following the company’s announcement of promising in vitro data for its lead drug candidate Telomir-1.
Check out the current price of TELO stock here.